RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Kappe, Oliver
Sommer, Florian
Cantillo, David
Abrégé
The present disclosure relates to an electrochemical reactor capable of processing an organic mixture comprising a suspension of a solid and a liquid, wherein the electrochemical reactor comprises an inner electrode, an outer electrode, wherein the inner electrode and the outer electrode are arranged concentrically forming a first cavity therebetween, a first inlet configured for introducing the liquid into the first cavity of the electrochemical reactor, a second inlet configured for introducing the solid into the first cavity of the electrochemical reactor, wherein the first inlet and the second inlet are arranged such that the liquid and the solid are introduced separately, wherein the inner electrode is configured to be rotatable around its longitudinal axis, wherein the inner electrode comprises one or more mixing elements. The present disclosure further relates to processes for the electrochemical N-demethylation and N- and O-demethylation, respectively, of an opioid precursor by means of the electrochemical reactor. The present disclosure further relates to a one-pot process for the N- and O-demethylation of an opioid precursor.
C25B 9/30 - Cellules ou assemblages de cellules comprenant des électrodes mobiles, p. ex. des électrodes rotativesAssemblages de leurs éléments de structure
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Klein, Thomas
Khinast, Johannes
Abrégé
A method of managing a multi-medicine manufacturing facility (100) configured for manufacturing a selected medicine (236) of a set of supported medicines on demand, wherein the method comprises stocking a set of different active pharmaceutical ingredients (102) each in a different one of a set of storage containers (104) separately from excipients (108) under long-term storage conditions, provisioning a set of pre-approved recipes (106) for manufacturing each of the said set of supported medicines by executing a predefined manufacturing process using at least one of said active pharmaceutical ingredients (102) in a predefined formulation at the multi-medicine manufacturing facility (100), forecasting a development of at least one medicine-related parameter, and managing said stocking and/or said provisioning and/or manufacturing of a selected medicine (236) on demand based on said forecasting.
G16H 20/13 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients delivrés par des distributeurs
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
3.
LOW COHERENCE INTERFEROMETRY IN THE MANUFACTURING OF AN UNCOATED PHARMACEUTICAL PRODUCT
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Fink, Elisabeth
Rehrl, Jakob
Sacher, Stephan
Khinast, Johannes
Abrégé
A method of predicting a characteristic of an uncoated pharmaceutical product (101) during a manufacturing process, the method comprising (i) performing the manufacturing process of the uncoated pharmaceutical product (101); and (ii) monitoring the uncoated pharmaceutical product (101), in particular simultaneously, during the manufacturing process; wherein the property of the uncoated pharmaceutical product is monitored using low coherence interferometry, LCI.
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Kushwah, Varun
Paudel, Amrit
Klein, Thomas
Khinast, Johannes
Abrégé
A method of monitoring a pharmaceutical product (101), the method comprising: manufacturing the pharmaceutical product (101) using a melt-solidification process; and monitoring the pharmaceutical product (101), in particular during the manufacturing process, using low coherence interferometry, LCI.
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Kappe, Oliver
Sommer, Florian
Cantillo, David
Abrégé
The present invention relates to an electrochemical reactor capable of processing an organic mixture comprising a suspension of a solid and a liquid, wherein the electrochemical reactor comprises an inner electrode, an outer electrode, wherein the inner electrode and the outer electrode are arranged concentrically forming a first cavity therebetween, a first inlet configured for introducing the liquid into the first cavity of the electrochemical reactor, a second inlet configured for introducing the solid into the first cavity of the electrochemical reactor, wherein the first inlet and the second inlet are arranged such that the liquid and the solid are introduced separately, wherein the inner electrode is configured to be rotatable around its longitudinal axis, wherein the inner electrode comprises one or more mixing elements. The present invention further relates to processes for the electrochemical N- demethylation and N- and O-demethylation, respectively, of an opioid precursor by means of the electrochemical reactor. The present invention further relates to a one-pot process for the N- and O-demethylation of an opioid precursor.
C25B 9/30 - Cellules ou assemblages de cellules comprenant des électrodes mobiles, p. ex. des électrodes rotativesAssemblages de leurs éléments de structure
C25B 9/67 - Moyens de chauffage ou de refroidissement
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Wolfgang, Matthias
Khinast, Johannes
Stranzinger, Sandra
Abrégé
A method of determining information indicative of a material attribute of a composition, wherein the method comprises manufacturing the composition using a thermal manufacturing process, detecting detection data from the composition by low coherence interferometry during the manufacturing, in particular during said thermal manufacturing process, and determining the information based on the detected detection data.
G01B 11/06 - Dispositions pour la mesure caractérisées par l'utilisation de techniques optiques pour mesurer la longueur, la largeur ou l'épaisseur pour mesurer l'épaisseur
7.
PROCESSES FOR PREPARING NOR-OPIOID COMPOUNDS AND OPIOID ANTAGONISTS BY ELECTROCHEMICAL N-DEMETHYLATION
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
KARL-FRANZENS-UNIVERSITÄT GRAZ (Autriche)
Inventeur(s)
Glotz, Gabriel
Cantillo Nieves, David
Kappe, Christian Oliver
Abrégé
The present invention relates to a process for preparing a nor-opioid compound wherein an opioid precursor compound is electrochemically N-demethylated. The present invention further relates to a process for preparing an opioid antagonist compound, wherein an opioid precursor compound is electrochemically N-demethylated and the thus obtained nor-opioid compound is alkylated again at its secondary amine functional group.
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
KARL-FRANZENS-UNIVERSITÄT GRAZ (Autriche)
TECHNISCHE UNIVERSITÄT GRAZ (Autriche)
Inventeur(s)
Eder, Simone
Koutsamanis, Ioannis
Klein, Thomas
Roblegg, Eva
Khinast, Johannes
Abrégé
The invention relates to a method for producing an active ingredient carrier, the method comprising: i) providing a polymer (112) for hot-melt extrusion (150), ii) feeding an expanding agent (113) to the polymer (112), and iii) extruding the polymer (112) by means of the hot-melt extrusion (150) in such a way that the expanding agent (113) produces, by means of a reaction, pores (121) in the polymer (112) which are suitable for transporting active ingredients, in order to provide the active ingredient carrier (120). The pores (121) which are suitable for transporting active ingredients are designed to receive an active ingredient (111) and/or release the active ingredient (111).
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Wolfgang, Matthias
Weissensteiner, Michael
Pöllitsch, Simon
Khinast, Johannes
Abrégé
A method of determining information indicative of a material attribute of a pharmaceutical composition (100), wherein the method comprises detecting detection data from the composition (100) by low coherence interferometry, and determining the information indicative of the material attribute based on the detection data and using machine learning.
G01N 15/14 - Techniques de recherche optique, p. ex. cytométrie en flux
G06K 9/00 - Méthodes ou dispositions pour la lecture ou la reconnaissance de caractères imprimés ou écrits ou pour la reconnaissance de formes, p.ex. d'empreintes digitales
10.
LOW COHERENCE INTERFEROMETRY ON COMPOSITIONS MANUFACTURED USING THERMAL MANUFACTURING PROCESSES
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Wolfgang, Matthias
Khinast, Johannes
Stranzinger, Sandra
Abrégé
A method of determining information indicative of a material attribute of a composition, wherein the method comprises manufacturing the composition using a thermal manufacturing process, detecting detection data from the composition by low coherence interferometry during the manufacturing, in particular during said thermal manufacturing process, and determining the information based on the detected detection data.
G01B 11/06 - Dispositions pour la mesure caractérisées par l'utilisation de techniques optiques pour mesurer la longueur, la largeur ou l'épaisseur pour mesurer l'épaisseur
G01N 21/84 - Systèmes spécialement adaptés à des applications particulières
09 - Appareils et instruments scientifiques et électriques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Computer software, In particular for pharmaceutical development; Software, Relating to the following purposes, Use in the field of pharmaceutical simulation; Simulation software, In particular for pharmacology; Instrumentation simulators, In particular for pharmaceutical applications; Application software for cloud computing services, In particular for pharmaceutical simulation. Scientific and technological services and research, In particular for pharmaceutical simulations; Industrial analysis and research services, In particular for pharmaceutical simulations; Computer software design, In particular for pharmaceutical development; Computerised analyses for pharmaceutical engineering; Design services for computer programs, Provision of computer programs, In particular for pharmaceutical simulations; Pharmaceutical research and development; Pharmaceutical products development; Inspection of pharmaceuticals; Pharmaceutical drug development services; Medical and pharmacological research services; Pharmaceutical product evaluation; Consultancy relating to pharmaceutical research and development; Scientific research in the field of pharmacy; Services for assessing the efficiency of pharmaceuticals; Information technology services for the pharmaceutical and healthcare industries; provision of information, in relation to the following fields, Results of studies relating to pharmaceutical goods; Development of computer programs for simulating laboratory experiments; Developing programs for simulating experiments or series of experiments in a virtual pharmaceutical laboratory; letting, in relation to the following goods, Computer software, Especially, Simulation software; Cloud computing, Especially, in relation to the following fields, Pharmaceutical development; Rental of operating software for accessing and using a cloud computing network, In particular relating to pharmaceutical simulations.
12.
System and a method for constant micro-dosing and feeding of powder material
Research Center Pharmaceutical Engineering GmbH (Autriche)
Inventeur(s)
Khinast, Johannes
Slama, Eyke
Fathollahi, Sara
Klein, Thomas
Besenhard, Maximilian
Abrégé
A system and a method for a constant micro dosing of powder material include a control device, a cylinder with a first opening and a piston movably arranged inside the cylinder and controllable by the control device. The piston is movable in the direction to or away from the first opening along a piston stroke direction. The cylinder stores the powder material between the piston and the first opening. The piston pushes the powder material through the first opening by moving along the piston stroke direction. Further the system and the method include a removing device for removing the powder material which is pushed out of the first opening of the cylinder. The control device controls the piston and the removing device in a synchronized manner such that a predetermined amount of powder material pushed through the first opening is removable by the removing device.
G01F 11/00 - Appareils qu'il faut actionner de l'extérieur, adaptés à chaque opération répétée et identique, pour mesurer et séparer le volume prédéterminé d'un fluide ou d'un matériau solide fluent à partir d'une alimentation ou d'un récipient sans tenir compte du poids, et pour fournir ce volume
B01J 8/00 - Procédés chimiques ou physiques en général, conduits en présence de fluides et de particules solidesAppareillage pour de tels procédés
B01J 4/00 - Dispositifs d'alimentationDispositifs de commande d'alimentation ou d'évacuation
B01J 4/02 - Dispositifs d'alimentationDispositifs de commande d'alimentation ou d'évacuation pour introduire des quantités mesurées de réactifs
G01F 11/02 - Appareils qu'il faut actionner de l'extérieur, adaptés à chaque opération répétée et identique, pour mesurer et séparer le volume prédéterminé d'un fluide ou d'un matériau solide fluent à partir d'une alimentation ou d'un récipient sans tenir compte du poids, et pour fournir ce volume avec chambres de mesure qui se dilatent ou se contractent au cours du mesurage
13.
Monitoring dissolution of a dosage form in progress during dissolution by low coherence interferometry
Research Center Pharmaceutical Engineering GmbH (Autriche)
Inventeur(s)
Bresciani, Massimo
Markl, Daniel
Mercuri, Annalisa
Khinast, Johannes
Klein, Thomas
Abrégé
A method of monitoring a property of a dissolution of an at least partially solid dosage form during a dissolution process is disclosed. The method includes at least partially dissolving the dosage form, and during the dissolution of the dosage form, simultaneously monitoring the property of the dissolution of the dosage form in progress by low coherence interferometry.
G01N 21/45 - RéfringencePropriétés liées à la phase, p. ex. longueur du chemin optique en utilisant des méthodes interférométriquesRéfringencePropriétés liées à la phase, p. ex. longueur du chemin optique en utilisant les méthodes de Schlieren
G01N 21/85 - Analyse des fluides ou solides granulés en mouvement
G01N 13/00 - Recherche des effets de surface ou de couche limite, p. ex. pouvoir mouillantRecherche des effets de diffusionAnalyse des matériaux en déterminant les effets superficiels, limites ou de diffusion
G01N 21/84 - Systèmes spécialement adaptés à des applications particulières
G01N 33/00 - Recherche ou analyse des matériaux par des méthodes spécifiques non couvertes par les groupes
14.
MONITORING A PROPERTY OF A FLUID DURING A FLOW PROCESS
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
KARL-FRANZENS-UNIVERSITÄT GRAZ (Autriche)
Inventeur(s)
Glotz, Gabriel
Kappe, Christian
Abrégé
A system for monitoring a property of a fluid during a flow process, the system comprising a flow apparatus, a supply apparatus configured to supply the fluid, and a monitoring apparatus configured for monitoring the property of the fluid during supplying the fluid by the supply apparatus. The flow apparatus comprises a flow unit which is movably arranged at a tube of the flow apparatus, wherein the fluid flows through the tube.
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
KARL-FRANZENS-UNIVERSITÄT GRAZ (Autriche)
Inventeur(s)
Glotz, Gabriel
Kappe, Christian Oliver
Dallinger, Doris
Lebl, Rene
Abrégé
The present invention relates to a process for generating cyanogen bromide (BrCN) comprising the steps of: mixing a fluid containing a bromine source with a fluid containing a cyanide source, reacting the bromine source and the cyanide source with each other to give a reaction mixture containing cyanogen bromide, and purifying the reaction mixture by means of a membrane-based separation to give (purified) cyanogen bromide. The present invention further relates to an apparatus configured for continuously generating cyanogen bromide and an apparatus configured for continuously generating bromine, which both apparatuses may be combined, as well as a process for synthesizing a nitrogen-containing compound.
C07D 417/12 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre et d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
16.
DEVICE AND METHOD FOR MEASURING A DENSITY OF PROVIDED GRANULAR MATTER
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
TECHNISCHE UNIVERSITÄT GRAZ (Autriche)
Inventeur(s)
Khinast, Johannes
Klein, Thomas
Bresciani, Massimo
Faulhammer, Eva
Stranzinger, Sandra
Markl, Daniel
Zeitler, Jochen Axel
Abrégé
A device and a method for providing granular matter is described, wherein the device comprises a receiving container (101) configured and adjusted for receiving the granular matter (103), wherein the receiving container (101) has an output (104) for providing the granular matter (103) to a further processing and the device comprises a measuring unit (102) configured for measuring a density of the granular matter (103) in the receiving container (101) using terahertz spectroscopy.
G01N 21/3563 - CouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en recherchant l'effet relatif du matériau pour les longueurs d'ondes caractéristiques d'éléments ou de molécules spécifiques, p. ex. spectrométrie d'absorption atomique en utilisant la lumière infrarouge pour l'analyse de solidesPréparation des échantillons à cet effet
G01N 21/3581 - CouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en recherchant l'effet relatif du matériau pour les longueurs d'ondes caractéristiques d'éléments ou de molécules spécifiques, p. ex. spectrométrie d'absorption atomique en utilisant la lumière infrarouge en utilisant la lumière de l'infrarouge lointainCouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en recherchant l'effet relatif du matériau pour les longueurs d'ondes caractéristiques d'éléments ou de molécules spécifiques, p. ex. spectrométrie d'absorption atomique en utilisant la lumière infrarouge en utilisant un rayonnement térahertz
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Khinast, Johannes
Slama, Eyke
Fathollahi, Sara
Klein, Thomas
Besenhard, Maximilian
Abrégé
A system and a method for a constant micro dosing of powder material, comprising a control device,a cylinder comprising a first opening and a piston movably arranged inside the cylinder and controllable by the control device, wherein the piston is movable in the direction to or away from the first opening along a piston stroke direction. The cylinder is configured for storing the powder material between the piston and the first opening. The piston is configured for pushing the powder material through the first opening by moving along the piston stroke direction. Further the system and the method comprise a removing device for removing the powder material which is pushed out of the first opening of the cylinder. The control device is configured for controlling the piston and the removing device in a synchronized manner such that a predetermined amount of powder material pushed through the first opening is removable by the removing device.
G01F 11/02 - Appareils qu'il faut actionner de l'extérieur, adaptés à chaque opération répétée et identique, pour mesurer et séparer le volume prédéterminé d'un fluide ou d'un matériau solide fluent à partir d'une alimentation ou d'un récipient sans tenir compte du poids, et pour fournir ce volume avec chambres de mesure qui se dilatent ou se contractent au cours du mesurage
G01F 11/00 - Appareils qu'il faut actionner de l'extérieur, adaptés à chaque opération répétée et identique, pour mesurer et séparer le volume prédéterminé d'un fluide ou d'un matériau solide fluent à partir d'une alimentation ou d'un récipient sans tenir compte du poids, et pour fournir ce volume
18.
MONITORING DISSOLUTION OF A DOSAGE FORM IN PROGRESS DURING DISSOLUTION BY LOW COHERENCE INTERFEROMETRY
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Bresciani, Massimo
Markl, Daniel
Mercuri, Annalisa
Khinast, Johannes
Klein, Thomas
Abrégé
A method of monitoring a property of a dissolution of an at least partially solid dosage form (103) during a dissolution process, the method comprising at least partially dissolving the dosage form (103), and during the dissolution of the dosage form (103), simultaneously monitoring the property of the dissolution of the dosage form (103) in progress by using a monitoring apparatus (101) based on low coherence interferometry.
G01N 13/00 - Recherche des effets de surface ou de couche limite, p. ex. pouvoir mouillantRecherche des effets de diffusionAnalyse des matériaux en déterminant les effets superficiels, limites ou de diffusion
G01N 21/84 - Systèmes spécialement adaptés à des applications particulières
19.
HOT VISCOUS RAW MATERIAL LEAVING A COOLER PERFORATED BODY COOLING A CUTTER
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Treffer, Daniel
Khinast, Johannes
Grubbauer, Johann
Eitzlmayr, Andreas
Koscher, Gerold
Klein, Thomas
Abrégé
An apparatus (100) for manufacturing particles, wherein the apparatus (100) comprises a supply unit (102) adapted for supplying a viscous raw material, a perforated body (104) having a plurality of perforations (106) and arranged to receive the viscous raw material from the supply unit (102) to flow through the plurality of perforations (106), and a cutter (108) arranged so that the viscous raw material flowing out of the plurality of perforations (106) is cut into the particles by the cutter (108), wherein the apparatus (100) is configured so that, during manufacturing the particles, a temperature of at least a portion of the perforated body (104) is lower than a temperature of the viscous raw material flowing through the plurality of perforations (106), wherein the perforated body (104) and the cutter (108) are arranged relative to one another such that the cutter (108) is cooled by thermal exchange with the perforated body (104) during operation of the apparatus (100).
B29C 47/00 - Moulage par extrusion, c. à d. en exprimant la matière à mouler dans une matrice ou une filière qui lui donne la forme désirée; Appareils à cet effet (moulage par extrusion-soufflage B29C 49/04)
B29C 47/30 - Filières d'extrusion à plusieurs orifices
Research Center Pharmaceutical Engineering GmbH (Autriche)
Research Center for Non Destructive Testing GmbH (Autriche)
Inventeur(s)
Markl, Daniel
Hannesschlaeger, Guenther
Leitner, Michael
Sacher, Stephan
Koller, Daniel
Khinast, Johannes
Abrégé
A method and a device for monitoring a property of a coating of a solid dosage form during a coating process forming the coating of the solid dosage form are provided. The device comprises a coating apparatus configured for forming the coating on the solid dosage form, and a monitoring apparatus configured for monitoring the property of the coating of the solid dosage form in process, wherein at least a part of the monitoring apparatus is located so as to have insight in an interior of the coating apparatus, the interior accommodating the solid dosage form to be coated and a precursor for forming the coating, and wherein the monitoring apparatus is configured for monitoring the property of the coating of the solid dosage form simultaneously with and during a coating process using low coherence interferometry.
A61J 3/00 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration
G01N 21/84 - Systèmes spécialement adaptés à des applications particulières
G01B 11/06 - Dispositions pour la mesure caractérisées par l'utilisation de techniques optiques pour mesurer la longueur, la largeur ou l'épaisseur pour mesurer l'épaisseur
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
TECHNISCHE UNIVERSITÄT GRAZ (Autriche)
Inventeur(s)
Klein, Thomas
Khinast, Johannes
Abrégé
A device for preparing a filled pharmaceutical capsule on demand with a predetermined amount of an active pharmaceutical ingredient is described. The device comprises a container accommodation unit adapted for accommodating a pharmaceutical container, a filling unit adapted for filling the active pharmaceutical ingredient into the pharmaceutical capsule, and a controller adapted for controlling the amount of the active pharmaceutical ingredient filled into the pharmaceutical capsule,. Further, a pharmaceutical container is described. Moreover, a kit comprising the device for preparing a filled pharmaceutical capsule on demand and the pharmaceutical container is described. Furthermore, a method for preparing a filled pharmaceutical capsule on demand with a predetermined amount of an active pharmaceutical ingredient is described.
A61J 3/07 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration la forme de capsules ou de petits conteneurs similaires à absorber par voie buccale
A61J 7/04 - Dispositions pour l'indication ou le rappel du moment où l'on doit prendre des médicaments, p. ex. distributeurs programmés
22.
VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Aichner, Martin
Oberauner, Lisa
Liebminger, Stefan
Fürnkranz, Michael
Klein, Thomas
Khinast, Johannes
Berg, Gabriele
Abrégé
The present invention relates to methods and compositions for controlling microbial growth on a surface to be treated. More particularly, the invention is directed to a corresponding method comprising contacting the surface to be treated with one or more antimicrobial agents; and incubating the surface for a pre-selected period of time, wherein the one or more antimicrobial agents are volatile organic compounds produced by plant-associated microorganisms. In further aspects, the invention relates to a kit-of-parts and a composition, respectively, each comprising one or more volatile organic compounds produced by plantassociated microorganisms as defined herein.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
A01N 63/02 - Substances produites par, ou obtenues à partir de micro-organismes ou d'animaux
A01N 63/04 - Champignons microscopiques; Substances produites par, ou obtenues à partir de champignons microscopiques
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
D06M 16/00 - Traitement biochimique des fibres, fils, filés, tissus ou articles fibreux faits de ces matières, p. ex. enzymatique
23.
MULTI-LAYER TABLET FORMATION BY ADHERING TABLET BODIES TOGETHER
RESEARCH CENTER PHARMACEUTICAL ENGINEERING (Autriche)
Inventeur(s)
Khinast, Johannes
Klein, Thomas
Sirnik, Bernhard
Hofer, Johannes
Redlinger-Pohn, Jakob
Gruber, Michael
Abrégé
A method of manufacturing a multi-layer tablet, wherein the method comprises providing a first tablet body comprising a compressed first powder having a first pharmacologically active substance, providing a second tablet body comprising a compressed second powder having a second pharmacologically active substance, and forming the multi-layer tablet by adhering the first tablet body and the second tablet body together by an adhesive.
A61J 3/10 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration la forme de tablettes comprimées
A61J 3/00 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration
B30B 5/06 - Presses caractérisées par l'emploi d'organes de pression autres que ceux mentionnés dans les groupes et dans lesquelles les organes de pression se présentent sous forme d'une bande sans fin coopérant avec une autre bande sans fin
B30B 11/34 - Presses spécialement adaptées à la fabrication d'objets à partir d'un matériau en grains ou à l'état plastique, p. ex. presses à briquettes ou presses à tablettes pour recouvrir des objets, p. ex. des tablettes
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Berg, Gabriele
Hartenberger, Kathrin
Liebminger, Stefan
Abrégé
The present invention relates to methods and compositions for controlling microbial growth on clean room equipment, preferably on clean room clothing. More particularly, the invention is directed to a corresponding method comprising contacting the clean room equipment to be treated with one or more antimicrobial agents; and incubating the clean room equipment for a pre-selected period of time, wherein the one or more antimicrobial agents are of organic origin. In a further aspect, the invention relates to a kit-of-parts, comprising one or more antimicrobial agents selected from the group consisting of microorganisms, preferably bacteria and fungi, and metabolites produced by said microorganisms for performing a method as defined herein.
A01N 25/34 - Formes façonnées, p. ex. feuilles, non prévues dans l'un quelconque des autres sous-groupes du présent groupe principal
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
A01N 63/02 - Substances produites par, ou obtenues à partir de micro-organismes ou d'animaux
A01N 63/04 - Champignons microscopiques; Substances produites par, ou obtenues à partir de champignons microscopiques
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
D06M 16/00 - Traitement biochimique des fibres, fils, filés, tissus ou articles fibreux faits de ces matières, p. ex. enzymatique
25.
A SYSTEM AND METHOD FOR MANUFACTURING A MEDICATION
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
Inventeur(s)
Khinast, Johannes
Brenn, Günter
Zimmer, Andreas
Eichinger, Rudolf
Bauer, Wolfgang
Abrégé
An apparatus for manufacturing a medication comprising an ejector unit adapted for ejecting a predefined amount of a drug having a liquid component to a solid carrier substrate. The ejector unit comprises a capillary and a tubular piezoelectric actuator surrounding at least a part of the capillary. The apparatus further comprises a control unit adapted for applying an electric signal to the piezoelectric actuator which, in response to the electric signal, is adapted to generate a compressional wave in the capillary for ejecting the predefined amount of the drug via an orifice of the capillary. Moreover, a method of manufacturing a medication is provided, the method comprising ejecting a predefined amount of a drug having a liquid component to a solid carrier substrate. Furthermore, a medication is provided comprising a solid carrier substrate, and a predefined amount of a drug ejected with a liquid component to the solid carrier substrate by an ejector unit.
A61J 3/00 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration
26.
PROCESSES FOR PREPARING NOR-OPIOID COMPOUNDS AND OPIOID ANTAGONISTS BY ELECTROCHEMICAL N-DEMETHYLATION
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (Autriche)
KARL-FRANZENS-UNIVERSITAT GRAZ (Autriche)
Inventeur(s)
Glotz, Gabriel
Cantillo Nieves, David
Kappe, Christian Oliver
Abrégé
The present invention relates to a process for preparing a nor-opioid compound wherein an opioid precursor compound is electrochemically N-demethylated. The present invention further relates to a process for preparing an opioid antagonist compound, wherein an opioid precursor compound is electrochemically N-demethylated and the thus obtained nor-opioid compound is alkylated again at its secondary amine functional group.